Search for: "Medco"
Results 1 - 20
of 169
Sort by Relevance
|
Sort by Date
1 May 2024, 1:18 pm
A version of this article appeared in Law360: Expert Analysis on April 25, 2024. [read post]
21 Apr 2024, 7:06 pm
Law No. 112-029), titled “Calculation of 60-Day Period for Application of Patent Term Extension” and referred to by some as “The Dog Ate My Homework Act” or the “Medco Fix. [read post]
16 Jun 2023, 12:11 pm
Medco Health Solutions, 880 F.3d 89 (3d Cir. 2018). [read post]
23 May 2023, 1:09 pm
Medco Health Sols., Inc., 880 F.3d 89, 98 (3d Cir. 2018). [read post]
7 Apr 2023, 8:00 am
Medco Health Solutions, Inc., 880 F.3d 89 (3d Cir. 2018) considered the issue. [read post]
17 Feb 2023, 8:17 am
The post $2.5M capital grant to spur MEDCO development in southern Md. first appeared on Maryland Daily Record. [read post]
5 Dec 2022, 1:03 pm
Medco Health Solutions, 880 F.3d 89 (3d Cir. 2018) is a landmark case in the Third Circuit involving interpretations of kickbacks, misused funds and specialty pharmaceuticals. [read post]
27 Sep 2022, 9:05 pm
Medco Health Solutions, Inc., 880 F.3d 89 (3d Cir. 2018). [read post]
18 Nov 2021, 1:03 pm
From Doe v. [read post]
2 Jul 2020, 10:36 am
Medco Health Solutions, Inc. constrained its analysis to the four corners of the fax. [read post]
25 Oct 2018, 12:18 pm
Medco [read post]
11 Sep 2018, 6:30 am
You may just end up getting a MEDCO-14 signed by a physician in the practice. [read post]
6 Feb 2018, 12:20 pm
The Medicines Co (MedCo) v. [read post]
2 Feb 2018, 12:36 pm
Medco Health Solutions, Inc. [read post]
17 Jan 2018, 6:22 am
Finally, O’Malley argued that the Helsinn panel is consistent with the en banc MedCo decision. [read post]
24 Sep 2017, 5:04 pm
In June, Helsinn filed for en banc review with support from the big players: Helsinn-Petition Teva-Response AIPLA (prior “on sale” activity must make the invention available to the public) BIO (negative consequences will flow from the panel decision) Boston (court should take the case and decide the issue) IPO (court should rule en banc, decision is contrary to MedCo) PhRMA (the legislative history “reflects [Congress’s]… [read post]
14 Apr 2017, 4:00 am
The post Mylan’s proposed ANDA drug does not infringe MedCo patents appeared first on IPWatchdog.com | Patents & Patent Law. [read post]
9 Apr 2017, 8:01 pm
by Dennis Crouch MedCo v. [read post]
6 Mar 2017, 7:33 am
Medco Health Solutions, in 2009, Gorsuch wrote a concurring opinion, in a case finding that an injury fell within an arbitration clause, that objected to circuit doctrine distinguishing between “broad” and “narrow” arbitration clauses: “There is nothing in the language of the Act that suggests some clauses are more equal than others – a sort of four legs good, two legs bad… Our job is always to enforce the parties’ intent and, absent such… [read post]
20 Feb 2017, 7:02 am
“I don’t understand how this is anything other than a termination for supporting public policy in Ohio. [read post]
